HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linong Ji Selected Research

Neoplasms by Site

11/2020Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linong Ji Research Topics

Disease

170Type 2 Diabetes Mellitus (MODY)
06/2022 - 11/2002
30Hypoglycemia (Reactive Hypoglycemia)
06/2022 - 09/2011
23Body Weight (Weight, Body)
09/2021 - 09/2011
18Insulin Resistance
12/2021 - 11/2009
15Hyperglycemia
03/2022 - 09/2011
14Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 12/2012
13Hypertension (High Blood Pressure)
05/2021 - 01/2013
12Obesity
01/2022 - 01/2013
11Weight Loss (Weight Reduction)
01/2022 - 01/2013
10Weight Gain
01/2022 - 01/2017
10Albuminuria
01/2022 - 01/2014
10Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 04/2015
10Prediabetic State (Prediabetes)
01/2022 - 03/2010
8Diabetes Mellitus
01/2022 - 01/2013
8Overweight
01/2022 - 01/2013
8Glucose Intolerance
01/2020 - 11/2009
7Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 02/2013
7Diabetic Nephropathies (Diabetic Nephropathy)
07/2021 - 01/2016
6Heart Failure
06/2022 - 01/2020
5Diabetic Retinopathy (Retinopathy, Diabetic)
07/2022 - 01/2014
5Dyslipidemias (Dyslipidemia)
03/2019 - 01/2013
4Neoplasms (Cancer)
11/2020 - 01/2019
4Osteoporosis
01/2020 - 01/2019
4Infections
08/2017 - 01/2014
3Chronic Renal Insufficiency
06/2022 - 01/2020
3Non-alcoholic Fatty Liver Disease
03/2022 - 01/2019
3Kidney Diseases (Kidney Disease)
12/2021 - 04/2020
3Myocardial Infarction
07/2021 - 01/2017
3Stroke (Strokes)
01/2020 - 01/2017
3Diabetes Complications
03/2019 - 04/2016
3Urinary Tract Infections (Urinary Tract Infection)
03/2019 - 01/2014
2Fatty Liver
06/2022 - 03/2022
2Respiratory Tract Infections (Respiratory Tract Infection)
03/2022 - 01/2021
2Renal Glycosuria
03/2022 - 01/2017
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2019
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
09/2021 - 01/2019
2Ketosis
07/2021 - 02/2013
2Graves Disease (Basedow Disease)
05/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

76Glucose (Dextrose)FDA LinkGeneric
06/2022 - 11/2009
49Insulin (Novolin)FDA Link
01/2022 - 11/2009
27Hypoglycemic Agents (Hypoglycemics)IBA
06/2022 - 09/2011
26Metformin (Glucophage)FDA LinkGeneric
01/2022 - 01/2013
23Blood Glucose (Blood Sugar)IBA
05/2022 - 10/2013
16LipidsIBA
12/2021 - 01/2013
15Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022 - 01/2012
14Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2021 - 01/2014
10Sodium-Glucose Transport ProteinsIBA
07/2022 - 01/2014
10Pharmaceutical PreparationsIBA
12/2021 - 01/2013
10Insulin Glargine (Lantus)FDA Link
09/2021 - 01/2016
10Dipeptidyl-Peptidase IV InhibitorsIBA
01/2021 - 05/2015
8Sodium-Glucose Transporter 2 InhibitorsIBA
03/2022 - 01/2017
8Glucagon-Like Peptide 1 (GLP 1)IBA
09/2021 - 01/2012
7AlbuminsIBA
01/2022 - 01/2015
7SodiumIBA
01/2022 - 01/2019
7Glucagon-Like Peptide-1 ReceptorIBA
01/2022 - 12/2017
7LDL CholesterolIBA
12/2021 - 09/2014
7CreatinineIBA
11/2021 - 01/2014
7Exenatide (Byetta)FDA Link
08/2021 - 01/2012
7Hemoglobins (Hemoglobin)IBA
07/2021 - 01/2013
7ORALIT (ORS)IBA
12/2019 - 01/2013
6Biomarkers (Surrogate Marker)IBA
03/2022 - 09/2015
6Triglycerides (Triacylglycerol)IBA
01/2019 - 04/2016
5LinagliptinIBA
03/2022 - 03/2015
5ThiazolidinedionesIBA
01/2022 - 01/2016
5Uric Acid (Urate)IBA
12/2021 - 11/2016
5oxidized low density lipoproteinIBA
12/2021 - 04/2016
5Sitagliptin Phosphate (Januvia)FDA Link
01/2021 - 01/2016
5dapagliflozinIBA
04/2019 - 01/2014
5Glycoside Hydrolase InhibitorsIBA
01/2019 - 01/2013
4GlucokinaseIBA
12/2021 - 01/2018
4C-PeptideIBA
11/2021 - 02/2013
4empagliflozinIBA
01/2021 - 01/2018
4Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2020 - 01/2014
4Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2019 - 05/2015
3Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2022 - 10/2020
3HDL CholesterolIBA
01/2022 - 04/2016
3AutoantibodiesIBA
01/2022 - 02/2013
3Glucagon (Glukagon)FDA Link
07/2021 - 01/2020
3Ferritins (Ferritin)IBA
06/2021 - 02/2017
3InsulinsIBA
03/2021 - 01/2016
3CholesterolIBA
01/2020 - 04/2016
3BilirubinIBA
01/2019 - 11/2016
3LiraglutideFDA Link
01/2019 - 01/2012
3saxagliptinFDA Link
01/2018 - 05/2016
3GlucosidasesIBA
01/2018 - 12/2015
3Insulin Detemir (Levemir)FDA Link
11/2017 - 03/2015
3Glyburide (Glibenclamide)FDA LinkGeneric
01/2017 - 01/2013
3Antihypertensive Agents (Antihypertensives)IBA
02/2016 - 01/2013
2Folic Acid (Vitamin M)FDA LinkGeneric
03/2022 - 01/2017
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
03/2022 - 09/2019
2Pioglitazone (Actos)FDA Link
01/2022 - 01/2017
2CanagliflozinIBA
01/2022 - 01/2019
2fibroblast growth factor 21IBA
12/2021 - 01/2021
2SymportersIBA
07/2021 - 01/2019
23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
04/2021 - 01/2021

Therapy/Procedure

56Therapeutics
06/2022 - 11/2009
30Glycemic Control
05/2022 - 12/2012
5Injections
11/2020 - 01/2016
4Bariatric Surgery
01/2019 - 06/2016
3Surgical Amputation (Amputations)
01/2021 - 03/2014